Report Detail
Global Fabry Disease Treatment Market Growth (Status and Outlook) 2019-2024
- RnM3114888 |
- 12 March, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Other
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
According to this study, over the next five years the Fabry Disease Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Fabry Disease Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Fabry Disease Treatment market by product type, application, key companies and key regions.
This study considers the Fabry Disease Treatment value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi S.A.
Shire Plc.
Amicus Therapeutics Inc.
ISU Abxis Co Ltd.
JCR Pharmaceuticals Co Ltd.
Protalix Biotherapeutics Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
Greenovation Biotech GmbH
Moderna Therapeutics Inc.
Green Cross Pharma Pte Ltd.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Fabry Disease Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Fabry Disease Treatment market by identifying its various subsegments.
Focuses on the key global Fabry Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fabry Disease Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Fabry Disease Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Fabry Disease Treatment Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Fabry Disease Treatment Market Size 2014-2024
- 2.1.2 Fabry Disease Treatment Market Size CAGR by Region
- 2.2 Fabry Disease Treatment Segment by Type
- 2.2.1 Enzyme Replacement Therapy (ERT)
- 2.2.2 Chaperone Treatment
- 2.2.3 Substrate Reduction Therapy (SRT)
- 2.2.4 Others
- 2.3 Fabry Disease Treatment Market Size by Type
- 2.3.1 Global Fabry Disease Treatment Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Fabry Disease Treatment Market Size Growth Rate by Type (2014-2019)
- 2.4 Fabry Disease Treatment Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Others
- 2.5 Fabry Disease Treatment Market Size by Application
- 2.5.1 Global Fabry Disease Treatment Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Fabry Disease Treatment Market Size Growth Rate by Application (2014-2019)
3 Global Fabry Disease Treatment by Players
- 3.1 Global Fabry Disease Treatment Market Size Market Share by Players
- 3.1.1 Global Fabry Disease Treatment Market Size by Players (2017-2019)
- 3.1.2 Global Fabry Disease Treatment Market Size Market Share by Players (2017-2019)
- 3.2 Global Fabry Disease Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Fabry Disease Treatment by Regions
- 4.1 Fabry Disease Treatment Market Size by Regions
- 4.2 Americas Fabry Disease Treatment Market Size Growth
- 4.3 APAC Fabry Disease Treatment Market Size Growth
- 4.4 Europe Fabry Disease Treatment Market Size Growth
- 4.5 Middle East & Africa Fabry Disease Treatment Market Size Growth
5 Americas
- 5.1 Americas Fabry Disease Treatment Market Size by Countries
- 5.2 Americas Fabry Disease Treatment Market Size by Type
- 5.3 Americas Fabry Disease Treatment Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Fabry Disease Treatment Market Size by Countries
- 6.2 APAC Fabry Disease Treatment Market Size by Type
- 6.3 APAC Fabry Disease Treatment Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Fabry Disease Treatment by Countries
- 7.2 Europe Fabry Disease Treatment Market Size by Type
- 7.3 Europe Fabry Disease Treatment Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Fabry Disease Treatment by Countries
- 8.2 Middle East & Africa Fabry Disease Treatment Market Size by Type
- 8.3 Middle East & Africa Fabry Disease Treatment Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Fabry Disease Treatment Market Forecast
- 10.1 Global Fabry Disease Treatment Market Size Forecast (2019-2024)
- 10.2 Global Fabry Disease Treatment Forecast by Regions
- 10.2.1 Global Fabry Disease Treatment Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Fabry Disease Treatment Forecast by Type
- 10.8 Global Fabry Disease Treatment Forecast by Application
11 Key Players Analysis
- 11.1 Sanofi S.A.
- 11.1.1 Company Details
- 11.1.2 Fabry Disease Treatment Product Offered
- 11.1.3 Sanofi S.A. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Sanofi S.A. News
- 11.2 Shire Plc.
- 11.2.1 Company Details
- 11.2.2 Fabry Disease Treatment Product Offered
- 11.2.3 Shire Plc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Shire Plc. News
- 11.3 Amicus Therapeutics Inc.
- 11.3.1 Company Details
- 11.3.2 Fabry Disease Treatment Product Offered
- 11.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Amicus Therapeutics Inc. News
- 11.4 ISU Abxis Co Ltd.
- 11.4.1 Company Details
- 11.4.2 Fabry Disease Treatment Product Offered
- 11.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 ISU Abxis Co Ltd. News
- 11.5 JCR Pharmaceuticals Co Ltd.
- 11.5.1 Company Details
- 11.5.2 Fabry Disease Treatment Product Offered
- 11.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 JCR Pharmaceuticals Co Ltd. News
- 11.6 Protalix Biotherapeutics Inc.
- 11.6.1 Company Details
- 11.6.2 Fabry Disease Treatment Product Offered
- 11.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Protalix Biotherapeutics Inc. News
- 11.7 Idorsia Pharmaceuticals Ltd.
- 11.7.1 Company Details
- 11.7.2 Fabry Disease Treatment Product Offered
- 11.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Idorsia Pharmaceuticals Ltd. News
- 11.8 Avrobio Inc.
- 11.8.1 Company Details
- 11.8.2 Fabry Disease Treatment Product Offered
- 11.8.3 Avrobio Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Avrobio Inc. News
- 11.9 Greenovation Biotech GmbH
- 11.9.1 Company Details
- 11.9.2 Fabry Disease Treatment Product Offered
- 11.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Greenovation Biotech GmbH News
- 11.10 Moderna Therapeutics Inc.
- 11.10.1 Company Details
- 11.10.2 Fabry Disease Treatment Product Offered
- 11.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Moderna Therapeutics Inc. News
- 11.11 Green Cross Pharma Pte Ltd.
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Fabry Disease Treatment. Industry analysis & Market Report on Fabry Disease Treatment is a syndicated market report, published as Global Fabry Disease Treatment Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Fabry Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
